Your browser doesn't support javascript.
loading
Risk-adjusted analysis of survival variability among hospitals treating biliary malignancy.
Rimini, Margherita; Casadei-Gardini, Andrea; Brandi, Giovanni; Leone, Francesco; Fornaro, Lorenzo; Pella, Nicoletta; Silvestris, Nicola; Montagnani, Francesco; Lonardi, Sara; Lai, Eleonora; Galizia, Eva; Santini, Daniele; Palloni, Andrea; Filippi, Roberto; Masi, Gianluca; Aprile, Giuseppe; Aglietta, Massimo; Frega, Giorgio; Fenocchio, Elisabetta; Vivaldi, Caterina; Satolli, Maria Antonietta; Salani, Francesca; Scartozzi, Mario; Faloppi, Luca; Pellino, Antonio; Sperti, Elisa; Burgio, Valentina; Ratti, Francesca; Aldrighetti, Luca; Cascinu, Stefano; Cucchetti, Alessandro.
Afiliação
  • Rimini M; Department of Oncology, IRCCS San Raffaele Scientific Institute Hospital, Milan, Italy.
  • Casadei-Gardini A; Department of Oncology, IRCCS San Raffaele Scientific Institute Hospital, Milan, Italy.
  • Brandi G; Department of Oncology, Vita-Salute San Raffaele University, Milan, Italy.
  • Leone F; Oncology Unit, Department of Experimental, Diagnostic and Specialty Medicine, Sant'Orsola-Malpighi Hospital, Bologna, Italy.
  • Fornaro L; Division of Medical Oncology, ASL BI, Nuovo Ospedale degli Infermi, Ponderano, BI, Italy.
  • Pella N; U.O. Oncologia Medica 2 Universitaria, Azienda Ospedaliero-Universitaria Pisana, Pisa, IT, Italy.
  • Silvestris N; Oncology Unit, University Hospital ASUFC, Udine, Italy.
  • Montagnani F; Department of Molecular Medicine, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Lonardi S; Department of Oncology, IRCCS Istituto Tumori "Giovanni Paolo II" of Bari, Bari, Italy.
  • Lai E; Division of Medical Oncology, ASL BI, Nuovo Ospedale degli Infermi, Ponderano, BI, Italy.
  • Galizia E; Oncology Unit 3, Department of Oncology, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
  • Santini D; Medical Oncology, University Hospital and University of Cagliari, Cagliari, Italy.
  • Palloni A; Macerata General Hospital, Medical Oncology Unit, Macerata, Italy.
  • Filippi R; Department of Medical Oncology, Campus Bio-Medico University of Rome, Rome, Italy.
  • Masi G; Oncology Unit, Department of Experimental, Diagnostic and Specialty Medicine, Sant'Orsola-Malpighi Hospital, Bologna, Italy.
  • Aprile G; Division of Medical Oncology, Candiolo Cancer Institute, FPO - IRCCS, Candiolo, TO, Italy.
  • Aglietta M; Department of Oncology, University of Turin, Torino, Italy.
  • Frega G; Centro Oncologico Ematologico Subalpino, Azienda Universitaria Ospedaliera Città della Salute e della Scienza di Torino, Torino, Italy.
  • Fenocchio E; U.O. Oncologia Medica 2 Universitaria, Azienda Ospedaliero-Universitaria Pisana, Pisa, IT, Italy.
  • Vivaldi C; Oncology Unit, University Hospital ASUFC, Udine, Italy.
  • Satolli MA; Division of Medical Oncology, Candiolo Cancer Institute, FPO - IRCCS, Candiolo, TO, Italy.
  • Salani F; Department of Oncology, University of Turin, Torino, Italy.
  • Scartozzi M; Oncology Unit, Department of Experimental, Diagnostic and Specialty Medicine, Sant'Orsola-Malpighi Hospital, Bologna, Italy.
  • Faloppi L; Multidisciplinary Outpatient Oncology Clinic, Candiolo Cancer Institute, FPO - IRCCS, Candiolo, TO, Italy.
  • Pellino A; U.O. Oncologia Medica 2 Universitaria, Azienda Ospedaliero-Universitaria Pisana, Pisa, IT, Italy.
  • Sperti E; Department of Oncology, University of Turin, Torino, Italy.
  • Burgio V; Centro Oncologico Ematologico Subalpino, Azienda Universitaria Ospedaliera Città della Salute e della Scienza di Torino, Torino, Italy.
  • Ratti F; U.O. Oncologia Medica 2 Universitaria, Azienda Ospedaliero-Universitaria Pisana, Pisa, IT, Italy.
  • Aldrighetti L; Medical Oncology, University Hospital and University of Cagliari, Cagliari, Italy.
  • Cascinu S; Macerata General Hospital, Medical Oncology Unit, Macerata, Italy.
  • Cucchetti A; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
J Chemother ; 34(8): 543-549, 2022 Dec.
Article em En | MEDLINE | ID: mdl-35156913
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Sistema Biliar / Desoxicitidina Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: J Chemother Assunto da revista: ANTINEOPLASICOS / TERAPIA POR MEDICAMENTOS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Sistema Biliar / Desoxicitidina Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: J Chemother Assunto da revista: ANTINEOPLASICOS / TERAPIA POR MEDICAMENTOS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália